Skip to content

To study the Effectiveness of herbal formulation - Aayudh Advance as a supplementary treatment for the Corona Virus 2019 (Covid-19) infected patients

A Randomized and Comparative Study to assess Safety and Efficacy of Supplemental Treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with Corona Virus 2019 (Covid-19)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025161
Enrollment
120
Registered
2020-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Herbal formulation - Aayudh Advance: Herbal formulation - Aayudh Advanced is a health supplement that helps boost immunity. This product is made from all-natural farm grown extracts. Ea

Sponsors

Ms Shukla Ashar Impex Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subject willing to sign informed consent. 2) Subject age group of 18 years and above of both gender. 3) All patients with COVID-19 RT-PCR positive (within 7 days)/ any Covid-19 test kit, admitted to the hospital / healthcare center will be eligible. 4) Patients who are having mild to moderate symptoms of Covid-19 disease and tested positive for Covid-19 test.

Exclusion criteria

Exclusion criteria: 1) Patient younger than18 years age. 2) Women who are pregnant or who intend to become pregnant for the next three months after taking the drug. 3) Patients allergic to type medications or any of the ingredient of the formulation. 4) Patients with a neurological history (seizures, epilepsy, etc.). 5) Patients with a previous history of psychiatric illnesses (depression, anxiety, suicide attempt). 6) Patients with severe cardiac pathologies or relevant chronic diseases that in the judgment of the clinician recommend the non-inclusion of the patient in the study. 7) Patients who are on artificial ventilation or oxygen supply. 8) Very severe patients of Covid 19. 9) Patients with severe hypertension, diabetes and other chronic diseases shall be excluded.

Design outcomes

Primary

MeasureTime frame
1) Rate of Recovery 2) Symptom Resolution: Fever 3) Symptom Resolution: Cough 4) Symptom Resolution: Shortness of breath Timepoint: Every 3-4 days from patient enrollment till recovery of patient and discharged from hospital

Secondary

MeasureTime frame
1) Questioning about any number of supplemental side effects observed. 2) Details of any adjunctive medication required during treatment due to supplemental treatment with herbal formulation - Aayudh Advance. 3) Total number of days till reaching the negative results for Covid-19. Timepoint: Every 3-4 days from patient enrollment till patient recovery and discharged from hospital

Countries

India

Contacts

Public ContactDr Manish Rachchh

Ganatra Ayurveda & Panchkarma Clinic

vd.ganatra@gmail.com9825497588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026